You searched for:

815 results

COVID-19 vaccine (adults) Patient Group Direction

This Patient Group Direction (PGD) is for the administration of COVID-19 vaccines to individuals aged 18 years and over, in accordance with the national COVID-19 vaccination programme.

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

COVID-19 vaccine (5 to 17 years of age) Patient Group Direction

This Patient Group Direction (PGD) is for the administration of COVID-19 vaccines to individuals aged 5 to 17 years, in accordance with the national COVID-19 vaccination programme.

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

Access to COVID treatments

Classification: Official Publication reference: PRN00532 To: cc. Dear Colleagues, Access to COVID treatments I am writing to confirm that following the publication of positive NICE recommendations for COVID treatments (TA878), integrated care boards (ICBs) will have responsibility for ensuring routine access to nirmatrelvir plus ritonavir (Paxlovid) and sotrovimab (Xevudy) for eligible patients from 27 June […]

Transition of COVID treatments to routine pathways

Classification: Official Publication reference: PR00337 27 March 2023 To: Integrated care board (ICB) chief medical officers (CMOs) ICB COVID therapeutics senior responsible officer (SROs) Regional chief pharmacists cc: Integrated care board: Directors of commissioning Chief operating officers Lead pharmacists Dear Colleagues, Transition of COVID treatments to routine pathways Thank you for the work you and […]